Fuji Pharma Co., Ltd.

TSE:4554 Stock Report

Market Cap: JP¥52.1b

Fuji Pharma Future Growth

Future criteria checks 4/6

Fuji Pharma is forecast to grow earnings and revenue by 24.3% and 7.8% per annum respectively. EPS is expected to grow by 24.7% per annum. Return on equity is forecast to be 10.9% in 3 years.

Key information

24.3%

Earnings growth rate

24.72%

EPS growth rate

Pharmaceuticals earnings growth12.7%
Revenue growth rate7.8%
Future return on equity10.90%
Analyst coverage

Low

Last updated26 Jun 2026

Recent future growth updates

Recent updates

Analysis Article • Feb 12

Fuji Pharma (TSE:4554) Is Due To Pay A Dividend Of ¥21.00

Fuji Pharma Co., Ltd. ( TSE:4554 ) will pay a dividend of ¥21.00 on the 2nd of June. Based on this payment, the...
Analysis Article • Feb 06

An Intrinsic Calculation For Fuji Pharma Co., Ltd. (TSE:4554) Suggests It's 24% Undervalued

Key Insights The projected fair value for Fuji Pharma is JP¥2,845 based on 2 Stage Free Cash Flow to Equity Current...
Analysis Article • Jan 08

Fuji Pharma (TSE:4554) Has Announced A Dividend Of ¥21.00

Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that it will pay a dividend of ¥21.00 per share on the 2nd of June...
Analysis Article • Dec 25

Fuji Pharma's (TSE:4554) Soft Earnings Are Actually Better Than They Appear

The market for Fuji Pharma Co., Ltd.'s ( TSE:4554 ) shares didn't move much after it posted weak earnings recently. We...
Analysis Article • Sep 22

Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥25.50

The board of Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that it will be paying its dividend of ¥25.50 on the 23rd...
Analysis Article • Aug 30

Fuji Pharma (TSE:4554) Is Paying Out A Larger Dividend Than Last Year

Fuji Pharma Co., Ltd. ( TSE:4554 ) will increase its dividend from last year's comparable payment on the 23rd of...
Analysis Article • Jul 17

Fuji Pharma's (TSE:4554) Dividend Will Be Increased To ¥25.50

The board of Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that it will be paying its dividend of ¥25.50 on the 23rd...
Analysis Article • May 21

Fuji Pharma's (TSE:4554) Soft Earnings Are Actually Better Than They Appear

Fuji Pharma Co., Ltd.'s ( TSE:4554 ) earnings announcement last week didn't impress shareholders. Despite the soft...
Analysis Article • Apr 08

These 4 Measures Indicate That Fuji Pharma (TSE:4554) Is Using Debt Extensively

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Dec 02

Fuji Pharma Co., Ltd. (TSE:4554) Held Back By Insufficient Growth Even After Shares Climb 27%

Fuji Pharma Co., Ltd. ( TSE:4554 ) shareholders have had their patience rewarded with a 27% share price jump in the...
Analysis Article • Nov 20

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Fuji Pharma Co., Ltd. ( TSE:4554 ) just reported some strong earnings, and the market reacted accordingly with a...
Analysis Article • Aug 05

Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop

Fuji Pharma Co., Ltd. ( TSE:4554 ) shareholders that were waiting for something to happen have been dealt a blow with a...
Analysis Article • Jul 22

Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year

The board of Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that the dividend on 23rd of December will be increased...
Analysis Article • Jul 03

Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Fuji Pharma Co., Ltd.'s ( TSE:4554 ) periodic dividend will be increasing on the 23rd of December to ¥22.50, with...
Analysis Article • Jun 19

Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

The board of Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that the dividend on 23rd of December will be increased...
Analysis Article • May 21

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Fuji Pharma Co., Ltd. ( TSE:4554 ) announced strong profits, but the stock was stagnant. Our analysis suggests that...
Analysis Article • May 13

Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

The board of Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that it will be paying its dividend of ¥22.50 on the 23rd...
Analysis Article • Feb 28

Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

Fuji Pharma Co., Ltd. ( TSE:4554 ) has announced that it will pay a dividend of ¥20.00 per share on the 3rd of June...

Earnings and Revenue Growth Forecasts

TSE:4554 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202871,3535,8763,0627,7102
9/30/202765,2475,2203,1556,7282
9/30/202659,5931,980-2,2969892
3/31/202657,2982,4264,3787,730N/A
12/31/202554,5742,333N/AN/AN/A
9/30/202551,6773,0001,9475,801N/A
6/30/202549,9373,066N/AN/AN/A
3/31/202548,8453,1762,8196,727N/A
12/31/202448,3924,398N/AN/AN/A
9/30/202446,1386,146-2214,151N/A
6/30/202444,5626,363N/AN/AN/A
3/31/202443,0525,920-5,278-44N/A
12/31/202341,6395,060N/AN/AN/A
9/30/202340,8893,435-1,9801,917N/A
6/30/202338,4382,036N/AN/AN/A
3/31/202336,9252,634-1,9441,934N/A
12/31/202235,9762,692N/AN/AN/A
9/30/202235,4262,696-13,081-658N/A
6/30/202234,9622,433N/AN/AN/A
3/31/202234,4392,245-11,551512N/A
12/31/202134,1412,222N/AN/AN/A
9/30/202133,9902,4322,0975,993N/A
6/30/202134,3923,161N/AN/AN/A
3/31/202134,1653,7964,9467,733N/A
12/31/202034,1202,668N/AN/AN/A
9/30/202033,7932,0853,1555,770N/A
6/30/202033,8542,006N/AN/AN/A
3/31/202034,7011,5774,4647,196N/A
12/31/201934,9682,611N/AN/AN/A
9/30/201936,2792,962N/A7,035N/A
6/30/201937,3613,287N/AN/AN/A
3/31/201938,4313,324N/A4,352N/A
12/31/201838,2313,167N/AN/AN/A
9/30/201837,9093,372N/A3,773N/A
6/30/201837,2433,219N/AN/AN/A
3/31/201836,0243,255N/A3,489N/A
12/31/201736,4123,525N/AN/AN/A
9/30/201735,3873,301N/A3,238N/A
6/30/201735,2173,141N/AN/AN/A
3/31/201734,7172,835N/A4,138N/A
12/31/201634,2342,650N/AN/AN/A
9/30/201634,2292,118N/A4,509N/A
6/30/201633,7082,354N/AN/AN/A
3/31/201633,0562,293N/A2,257N/A
12/31/201532,5402,121N/AN/AN/A
9/30/201531,6802,092N/A589N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4554's forecast earnings growth (24.3% per year) is above the savings rate (0.8%).

Earnings vs Market: 4554's earnings (24.3% per year) are forecast to grow faster than the JP market (9.9% per year).

High Growth Earnings: 4554's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 4554's revenue (7.8% per year) is forecast to grow faster than the JP market (6.5% per year).

High Growth Revenue: 4554's revenue (7.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4554's Return on Equity is forecast to be low in 3 years time (10.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/01 08:54
End of Day Share Price 2026/07/01 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fuji Pharma Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masao YoshidaIchiyoshi Research Institute Inc.
Shigekazu IshidaMarusan Securities Co. Ltd.
Yuriko IshidaMizuho Securities Co., Ltd.